Trails Edge Capital Partners manages investments for private funds using a master feeder structure. They focus on long and short positions in biotechnology and pharmaceutical companies, particularly mid- and small-capitalization companies. Trails Edge uses fundamental analysis to identify market inefficiencies. They may also invest in illiquid private securities. Trails Edge does not provide tailored advice to individual investors.
Fee Structure
Trails Edge Capital Partners manages investments for private funds and receives a management fee. This fee is generally 1.8% to 2.0% annually, depending on the class interests of the funds. The fee is calculated monthly in advance based on the net asset value of each investor's capital account. The firm may reduce or waive the management fee for certain investors, such as the Principal, employees, or their families.